ENZYME entry: EC 1.14.13.181
| Accepted Name | ||||
|---|---|---|---|---|
| 13-deoxydaunorubicin hydroxylase | ||||
| Reaction catalysed | ||||
| ||||
| Comment(s) | ||||
| The enzymes from the Gram-positive bacteria Streptomyces sp. C5 and Streptomyces peucetius show broad substrate specificity for structures based on an anthracycline aglycone, but have a strong preference for 4-methoxy anthracycline intermediates (13-deoxydaunorubicin and 13-dihydrodaunorubicin) over their 4-hydroxy analogs (13-deoxycarminomycin and 13-dihydrocarminomycin), as well as a preference for substrates hydroxylated at the C-13 rather than the C-14 position. | ||||
| Cross-references | ||||
| BRENDA | 1.14.13.181 | |||
| EC2PDB | 1.14.13.181 | |||
| ExplorEnz | 1.14.13.181 | |||
| KEGG Ligand Database for Enzyme Nomenclature | 1.14.13.181 | |||
| IUBMB Enzyme Nomenclature | 1.14.13.181 | |||
| MEDLINE | Find literature relating to 1.14.13.181 | |||
| MetaCyc | 1.14.13.181 | |||
| Rhea expert-curated reactions | 1.14.13.181 | |||
| UniProtKB/Swiss-Prot |
| |||
View entry in original ENZYME format
View entry in raw text format (no links)
All UniProtKB/Swiss-Prot
entries referenced
in this entry, with possibility to download in different formats, align etc.
All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.14.13.-All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.14.-.-
All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.-.-.-